专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

61. 发明授权

US08072946B2 Coordinated transmissions in wireless networks 有权
标题翻译：无线网络中的协调传输
公开(公告)号：US08072946B2
公开(公告)日：2011-12-06
申请号：US11394464
申请日：2006-03-30
申请人： Guoqing Li , Qinghua Li , Xintian E. Lin
发明人： Guoqing Li , Qinghua Li , Xintian E. Lin
IPC分类号： H04W4/00
CPC分类号： H04W28/18 , H04B7/0491 , H04W24/00
摘要： Overall network throughput may be increased in a wireless network through coordinated transmission between wireless network stations. A wireless network station selects beamforming information based at least in part on interference to other wireless network stations.
摘要翻译：通过无线网络站之间的协调传输，可以在无线网络中增加总体网络吞吐量。无线网络站至少部分地基于对其他无线网络站的干扰来选择波束形成信息。

62. 发明申请

US20110268003A1 Method for Enhancing User Equipment (UE) Power Saving Performance and UE 有权
标题翻译：增强用户设备（UE）节能性能和UE的方法
公开(公告)号：US20110268003A1
公开(公告)日：2011-11-03
申请号：US13127210
申请日：2009-11-03
申请人： Guoqing Li , Li Chen , Zhuo Gao
发明人： Guoqing Li , Li Chen , Zhuo Gao
IPC分类号： H04W52/02
CPC分类号： H04W52/0216 , H04W76/28 , Y02D70/1262 , Y02D70/24
摘要： A method for enhancing power saving performance of user equipment (UE) is provided. The method includes the following steps: a UE receives the downlink data transmitted by an evolved node B (eNB); the UE starts a corresponding RTT Timer according to the received downlink data, the timing of the RTT Timer is determined based on the uplink/downlink (UL/DL) configuration and the sub-frame number of the downlink sub-frame carrying the downlink data by the UE; and the UE controls the discontinuous reception (DRX) process according to the RTT Timer. By re-defining the RTT Timer, the present invention can improve power saving performance of the UE in TDD system effectively.
摘要翻译：提供了一种用于提高用户设备（UE）的节电性能的方法。该方法包括以下步骤：UE接收由演进节点B（eNB）发送的下行数据; UE根据接收到的下行链路数据启动相应的RTT定时器，根据上行链路/下行链路（UL / DL）配置和携带下行链路数据的下行链路子帧的子帧号确定RTT定时器的定时由UE; 并且UE根据RTT定时器控制不连续接收（DRX）处理。通过重新定义RTT定时器，本发明可以有效地提高TDD系统中UE的功率节省性能。

63. 发明申请

US20110151840A1 ENHANCED SERVICE DISCOVERY MECHANISM IN WIRELESS COMMUNICATION SYSTEM 有权
标题翻译：无线通信系统中增强服务发现机制
公开(公告)号：US20110151840A1
公开(公告)日：2011-06-23
申请号：US12644567
申请日：2009-12-22
申请人： Michelle Gong , Guoqing Li
发明人： Michelle Gong , Guoqing Li
IPC分类号： G06Q30/00 , H04M3/42
CPC分类号： H04W48/12 , G06Q30/0267 , H04L67/16 , H04W80/02 , H04W84/12
摘要： According to various embodiments, an apparatus and method are disclosed that are configured to transmit from a controller to associated mobile stations an advertising message including an advertising information element indicative of the establishment of the new association of a new service provider capable of providing at least one particular service.
摘要翻译：根据各种实施例，公开了一种设备和方法，其被配置为从控制器向相关联的移动台发送包括广告信息元素的广告消息，所述广告消息包括指示新服务提供商的新关联的建立能够提供至少一个特殊服务。

64. 发明授权

US07910590B2 Cyclic amine bace-1 inhibitors having a heterocyclic substituent 有权
标题翻译：具有杂环取代基的环胺类bace-1抑制剂
公开(公告)号：US07910590B2
公开(公告)日：2011-03-22
申请号：US12490884
申请日：2009-06-24
申请人： Ying Huang , Guoqing Li , Ulrich Iserloh , Andrew Stamford , Corey Strickland , Johannes H. Voigt , Jianping Pan
发明人： Ying Huang , Guoqing Li , Ulrich Iserloh , Andrew Stamford , Corey Strickland , Johannes H. Voigt , Jianping Pan
IPC分类号： A61K31/496 , A61K31/506
CPC分类号： C04B35/632 , C07D207/277 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/14
摘要： Disclosed are novel compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is X is —O—, —C(R 14)2— or —N(R)—; Z is —C(R14)2— or —N(R)—; t is 0, 1, 2 or 3; each R and R2 is independently H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, alkenyl or alkynyl; each R14 is H, alkyl, alkenyl, alkynyl, halo, —CN, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, —OR35, —N(R24)(R25) or —SR35; R41 is alkyl, cycloalkyl, —SO2(alkyl), —C(O)-alkyl, —C(O)-cycloalkyl or -alkyl-NH—C(O)CH3; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating cognitive or neurodegenerative diseases with compounds of formula I.Also disclosed are pharmaceutical compositions and methods of treatment comprising compounds of formula I in combination with other agents useful in treating cognitive or neurodegenerative diseases.
摘要翻译：公开了下式的新化合物或其药学上可接受的盐或溶剂合物，其中R 1是X是-O - ， - C（R 14）2 - 或-N（R） - ; Z是-C（R 14）2 - 或-N（R） - ; t为0,1,2或3; 每个R和R 2独立地为H，烷基，环烷基，环烷基烷基，芳基，杂芳基，杂环烷基，芳基烷基，杂芳基烷基，杂环烷基烷基，烯基或炔基; 每个R 14是H，烷基，烯基，炔基，卤素，-CN，卤代烷基，环烷基，环烷基烷基，芳基，杂芳基，杂环烷基，芳基烷基，杂芳基烷基，杂环烷基烷基，-OR 35，-N（R 24）（R 25）或-SR 35; R41是烷基，环烷基，-SO2（烷基），-C（O） - 烷基，-C（O） - 环烷基或 - 烷基-NH-C（O）CH3; 其余变量如本说明书中所定义。还公开了包含式I化合物的药物组合物和用式I化合物治疗认知障碍或神经变性疾病的方法。还公开了药物组合物和治疗方法，其包含式I化合物与用于治疗认知或神经变性的其它药剂疾病

65. 发明申请

US20100178294A1 MACROCYCLIC BETA-SECRETASE INHIBITORS 有权
标题翻译：大分子β-分泌酶抑制剂
公开(公告)号：US20100178294A1
公开(公告)日：2010-07-15
申请号：US12571840
申请日：2009-10-01
申请人： Andrew W. Stamford , Ying Huang , Guoqing Li , Corey O. Strickland , Johannes H. Voigt
发明人： Andrew W. Stamford , Ying Huang , Guoqing Li , Corey O. Strickland , Johannes H. Voigt
IPC分类号： A61K39/395 , C07D413/06 , A61K31/496 , C07D498/04 , A61P25/28 , A61P25/00
CPC分类号： C07D498/04 , C07D413/06
摘要： Disclosed are novel compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, R3, n and X are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I.Also disclosed are methods of treating cognitive or neurodegenerative diseases such as Alzheimer's disease.Also disclosed are methods of treating a cognitive or neurodegenerative disease comprising administering to a patient I need of such treatment a combination of at least one compound of formula I and at least one compound selected from the group consisting of β-secretase inhibitors other than those of formula I, HMG-CoA reductase inhibitors, gamma-secretase inhibitors, non-steroidal anti-inflammatory agents, N-methyl-D-aspartate receptor antagonists, cholinesterase inhibitors and anti-amyloid antibodies.
摘要翻译：公开了下式的新化合物或其药学上可接受的盐或溶剂化物，其中R1，R2，R3，n和X如说明书中所定义。还公开了包含式I化合物的药物组合物。还公开了治疗认知或神经变性疾病如阿尔茨海默病的方法。还公开了治疗认知或神经退行性疾病的方法，包括向需要这种治疗的患者施用至少一种式I化合物和至少一种选自除了那些的那些之外的其他化合物式I，HMG-CoA还原酶抑制剂，γ-分泌酶抑制剂，非甾体抗炎剂，N-甲基-D-天冬氨酸受体拮抗剂，胆碱酯酶抑制剂和抗淀粉样蛋白抗体。

66. 发明申请

US20070232235A1 Coordinated transmissions in wireless networks 有权
标题翻译：无线网络中的协调传输
公开(公告)号：US20070232235A1
公开(公告)日：2007-10-04
申请号：US11394464
申请日：2006-03-30
申请人： Guoqing Li , Qinghua Li , Xintian Lin
发明人： Guoqing Li , Qinghua Li , Xintian Lin
IPC分类号： H04B1/00
CPC分类号： H04W28/18 , H04B7/0491 , H04W24/00
摘要： Overall network throughput may be increased in a wireless network through coordinated transmission between wireless network stations. A wireless network station selects beamforming information based at least in part on interference to other wireless network stations.
摘要翻译：通过无线网络站之间的协调传输，可以在无线网络中增加总体网络吞吐量。无线网络站至少部分地基于对其他无线网络站的干扰来选择波束形成信息。

67. 发明申请

US20060040948A1 Macrocyclic beta-secretase inhibitors 有权
标题翻译：大环β-分泌酶抑制剂
公开(公告)号：US20060040948A1
公开(公告)日：2006-02-23
申请号：US11189346
申请日：2005-07-26
申请人： Andrew Stamford , Ying Huang , Guoqing Li , Corey Strickand , Johannes Voigt
发明人： Andrew Stamford , Ying Huang , Guoqing Li , Corey Strickand , Johannes Voigt
IPC分类号： A61K31/496 , C07D491/14
CPC分类号： C07D498/04 , C07D413/06
摘要： Disclosed are novel compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, R3, n and X are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I. Also disclosed are methods of treating cognitive or neurodegenerative diseases such as Alzheimer's disease. Also disclosed are methods of treating a cognitive or neurodegenerative disease comprising administering to a patient I need of such treatment a combination of at least one compound of formula I and at least one compound selected from the group consisting of β-secretase inhibitors other than those of formula I, HMG-CoA reductase inhibitors, gamma-secretase inhibitors, non-steroidal anti-inflammatory agents, N-methyl-D-aspartate receptor antagonists, cholinesterase inhibitors and anti-amyloid antibodies.
摘要翻译：公开了下式的新化合物或其药学上可接受的盐或溶剂化物，其中R 1，R 2，R 3，n和X 如说明书中所定义。还公开了包含式I化合物的药物组合物。还公开了治疗认知或神经变性疾病如阿尔茨海默病的方法。还公开了治疗认知或神经变性疾病的方法，其包括向需要这种治疗的患者施用至少一种式I化合物和至少一种选自β-分泌酶抑制剂的化合物的组合，所述β-分泌酶抑制剂除式I，HMG-CoA还原酶抑制剂，γ-分泌酶抑制剂，非甾体抗炎剂，N-甲基-D-天冬氨酸受体拮抗剂，胆碱酯酶抑制剂和抗淀粉样蛋白抗体。

68. 发明授权

US09369188B2 Link prediction based re-beamforming triggering algorithm for 60 ghz communication links 有权
标题翻译：基于链路预测的60Ghz通信链路的重新波束成形触发算法
公开(公告)号：US09369188B2
公开(公告)日：2016-06-14
申请号：US13993196
申请日：2011-12-13
申请人： Guoqing Li , Dmitry Akhmetov
发明人： Guoqing Li , Dmitry Akhmetov
IPC分类号： H04B7/06 , H04B7/04
CPC分类号： H04B7/0408 , H04B7/0617
摘要： A system and method are provided to trigger re-beamforming based on an algorithm that assesses various link characteristics. The algorithm is based on the ability of a 60 GHz receiving device to track and feedback a Received Signal Strength Indication (RSSI) to a 60 GHz data packet transmitter. By automatically analyzing RSSI values across a range of data packets, including consecutive data packets, a link degradation trend is predicted. When link degradation crosses, or is predicted to cross, a predetermined threshold, re-beamforming is triggered by the algorithm. Variables in the algorithm and the predetermined thresholds used by the algorithm can be automatically or manually modified to maintain a balance between appropriately triggering the re-beamforming when the conditions arise without unnecessarily triggering the re-beamforming thereby causing unneeded interruptions in regular data flow.
摘要翻译：提供了一种基于评估各种链路特性的算法来触发重新波束形成的系统和方法。该算法基于60GHz接收设备跟踪并将接收信号强度指示（RSSI）反馈到60GHz数据分组发射机的能力。通过自动分析包括连续数据包在内的数据包范围内的RSSI值，可以预测链路退化趋势。当链路劣化交叉或被预测为交叉预定阈值时，由该算法触发重新波束形成。可以自动地或手动地修改算法中使用的算法和预定阈值的变量，以便在条件出现时适当地触发重新波束形成之间保持平衡，而不必不必要地触发重新波束形成，从而导致规则数据流中不必要的中断。

69. 发明申请

US20150359000A1 MULTI-USER SCHEDULING CHANNEL STATUS REPORTING FOR WI-FI 审中-公开
标题翻译：用于WI-FI的多用户调度通道状态报告
公开(公告)号：US20150359000A1
公开(公告)日：2015-12-10
申请号：US14487767
申请日：2014-09-16
申请人： Qinghua LI , Huaning Niu , Robert Stacey , Guoqing Li , Hujun Yin , Rongzhen Yang
发明人： Qinghua LI , Huaning Niu , Robert Stacey , Guoqing Li , Hujun Yin , Rongzhen Yang
IPC分类号： H04W74/06 , H04W88/08
CPC分类号： H04W74/06 , H04W72/04 , H04W72/1278 , H04W72/1284 , H04W72/1289 , H04W84/12 , H04W88/08
摘要： Provided are systems and methods for polling, by a wireless network access point, a group of wireless network stations for an uplink transmission status, receiving (from one or more wireless network stations of the group of wireless network stations) an uplink transmission status report indicating that the wireless network station is ready for uplink data transmission, scheduling (in response to receiving the one or more uplink transmission status reports) one or more uplink data transmissions from the one or more wireless network stations, and receiving (from the one or more wireless network stations in accordance with the scheduling) one or more uplink data transmissions comprising uplink data.
摘要翻译：提供了一种系统和方法，用于通过无线网络接入点轮询用于上行链路传输状态的一组无线网络站，从（来自该组无线网络站的一个或多个无线网络站）接收指示的上行链路传输状态报告无线网络站准备好用于上行链路数据传输，调度（响应于接收到一个或多个上行链路传输状态报告）来自一个或多个无线网络站的一个或多个上行链路数据传输，以及从一个或多个无线网络站根据调度）一个或多个上行链路数据传输，其包括上行链路数据。

70. 发明授权

US09169260B2 Amidopyrazole inhibitors of interleukin receptor-associated kinases 有权
标题翻译：白介素受体相关激酶的吡咯唑抑制剂
公开(公告)号：US09169260B2
公开(公告)日：2015-10-27
申请号：US14006565
申请日：2012-03-21
申请人： William T. McElroy , Guoqing Li , Ginny Dai Ho , Zheng Tan , Sunil Paliwal , William Michael Seganish , Deen Tulshian , John Lampe , Joey L. Methot , Hua Zhou , Michael D. Altman , Liang Zhu
发明人： William T. McElroy , Guoqing Li , Ginny Dai Ho , Zheng Tan , Sunil Paliwal , William Michael Seganish , Deen Tulshian , John Lampe , Joey L. Methot , Hua Zhou , Michael D. Altman , Liang Zhu
IPC分类号： C07D487/04 , A61K31/519 , A61K31/4162
CPC分类号： C07D487/04 , A61K31/4162
摘要： This invention relates to amidopyrazole compounds that are inhibitors of Interleukin receptor-associated kinases, in particular IRAK-4, and are useful in the treatment of cellular proliferative diseases, for example, cancer, hyperplasia, restenosis, cardiac hypertrophy, immune disorders and inflammation.
摘要翻译：本发明涉及作为白介素受体相关激酶抑制剂，特别是IRAK-4的氨基吡唑化合物，可用于治疗细胞增殖性疾病，例如癌症，增生，再狭窄，心脏肥大，免疫疾病和炎症。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式